Immune checkpoint inhibitor induced thyroid dysfunction is a frequent event post-treatment in NSCLC
免疫检查点抑制剂诱发的甲状腺功能障碍是NSCLC治疗后常见的并发症。
期刊:Lung Cancer
影响因子:4.4
doi:10.1016/j.lungcan.2021.08.009
Zhou, Nanruoyi; Velez, Maria A; Bachrach, Benjamin; Gukasyan, Jaklin; Fares, Charlene M; Cummings, Amy L; Lind-Lebuffe, Jackson P; Akingbemi, Wisdom O; Li, Debory Y; Brodrick, Paige M; Yessuf, Nawal M; Rettinger, Sarah; Grogan, Tristan; Rochigneux, Philippe; Goldman, Jonathan W; Garon, Edward B; Lisberg, Aaron